Sentence examples for iii alternative from inspiring English sources

Three scenarios are designed: (i) "business as usual" (BAU); (ii) "advanced fuel economy" (AFE); and (iii) "alternative energy replacement" (AER).

Current experiments in our lab focus on the improvement of the screen by (i) the evaluation of novel chromophores that might have an improved FRET-efficiency, (ii) testing of other cells and transfection methods and (iii) alternative approaches to reisolate the plasmids from the sorted cells.

Sequencing of cloned cDNAs of this product indicated the existence of splice type III alternative splicing, which included both alternative exons, and retained the opening frame of the spliced RNA.

Such hybrid models may include (i) the truncated Gaussian model for a subset of priors with quantitative parameters, (ii) the simplified step function form for binary priors, and (iii) alternative forms (e.g., based on a bimodal distribution) for other priors.

The discrepancies were traced back to (i) annotation problems: Hmga1, Lin28, Phip, (ii) different length of 3'UTR sequences where location of the microarray probe would not query all transcripts arising from the respective genes: Sema3a, Rod1, Slc2a1, or (iii) alternative splicing: Ogt, Tfrc [ 26], Creb1 [ 27].

First, there are three alternative 3′ exons in mouse: exon III, exon VIIa, and exon X.

(iii) The alternative can be used without significant economic or practical disadvantages, including impacts on the so-called minor uses.

(iii) An alternative approach will be to divide the data dissemination process into several batches where in each batch, native packets are sent followed by the recovering process [24].

Studies have also shown the potential role of PARP1 and DNA LIGASE III in alternative pathway of NHEJ using in vivo plasmid rejoining assay.

All proposed changes, including the new trait-specific methodology, were moved to a separate area of the DSM-5 Section III titled "Alternative DSM-5 Model for Personality Disorders" (8), where proposals were placed that require further research.

Furthermore, the option for tailoring therapy among agents exists: (i) compliance, favoring once-daily rivaroxaban; (ii) concern for bleeding, favoring reduced-dose apixaban (2.5 mg twice daily); and (iii) warfarin alternative, favoring dabigatran.